Literature DB >> 35799833

Modeling pandemic to endemic patterns of SARS-CoV-2 transmission using parameters estimated from animal model data.

Sarah Mullin1, Brent Vander Wyk2, Jennifer L Asher3, Susan R Compton3, Heather G Allore2, Caroline J Zeiss3.   

Abstract

The contours of endemic coronaviral disease in humans and other animals are shaped by the tendency of coronaviruses to generate new variants superimposed upon nonsterilizing immunity. Consequently, patterns of coronaviral reinfection in animals can inform the emerging endemic state of the SARS-CoV-2 pandemic. We generated controlled reinfection data after high and low risk natural exposure or heterologous vaccination to sialodacryoadenitis virus (SDAV) in rats. Using deterministic compartmental models, we utilized in vivo estimates from these experiments to model the combined effects of variable transmission rates, variable duration of immunity, successive waves of variants, and vaccination on patterns of viral transmission. Using rat experiment-derived estimates, an endemic state achieved by natural infection alone occurred after a median of 724 days with approximately 41.3% of the population susceptible to reinfection. After accounting for translationally altered parameters between rat-derived data and human SARS-CoV-2 transmission, and after introducing vaccination, we arrived at a median time to endemic stability of 1437 (IQR = 749.25) days with a median 15.4% of the population remaining susceptible. We extended the models to introduce successive variants with increasing transmissibility and included the effect of varying duration of immunity. As seen with endemic coronaviral infections in other animals, transmission states are altered by introduction of new variants, even with vaccination. However, vaccination combined with natural immunity maintains a lower prevalence of infection than natural infection alone and provides greater resilience against the effects of transmissible variants.
© The Author(s) 2022. Published by Oxford University Press on behalf of the National Academy of Sciences.

Entities:  

Keywords:  SARS-CoV-2; endemic; infection; models; translational

Year:  2022        PMID: 35799833      PMCID: PMC9254158          DOI: 10.1093/pnasnexus/pgac096

Source DB:  PubMed          Journal:  PNAS Nexus        ISSN: 2752-6542


  94 in total

1.  Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event.

Authors:  Leen Vijgen; Els Keyaerts; Elien Moës; Inge Thoelen; Elke Wollants; Philippe Lemey; Anne-Mieke Vandamme; Marc Van Ranst
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

2.  Primary structure of the sialodacryoadenitis virus genome: sequence of the structural-protein region and its application for differential diagnosis.

Authors:  D Yoo; Y Pei; N Christie; M Cooper
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

3.  Rat respiratory coronavirus infection: replication in airway and alveolar epithelial cells and the innate immune response.

Authors:  C Joel Funk; Rizwan Manzer; Tanya A Miura; Steve D Groshong; Yoko Ito; Emily A Travanty; Jennifer Leete; Kathryn V Holmes; Robert J Mason
Journal:  J Gen Virol       Date:  2009-09-09       Impact factor: 3.891

4.  SARS-CoV-2 Transmission From People Without COVID-19 Symptoms.

Authors:  Michael A Johansson; Talia M Quandelacy; Sarah Kada; Pragati Venkata Prasad; Molly Steele; John T Brooks; Rachel B Slayton; Matthew Biggerstaff; Jay C Butler
Journal:  JAMA Netw Open       Date:  2021-01-04

5.  Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.

Authors:  Chris Davis; Nicola Logan; Grace Tyson; Richard Orton; William T Harvey; Jonathan S Perkins; Guy Mollett; Rachel M Blacow; Thomas P Peacock; Wendy S Barclay; Peter Cherepanov; Massimo Palmarini; Pablo R Murcia; Arvind H Patel; David L Robertson; John Haughney; Emma C Thomson; Brian J Willett
Journal:  PLoS Pathog       Date:  2021-12-02       Impact factor: 7.464

6.  Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape.

Authors:  Mary Bushman; Rebecca Kahn; Bradford P Taylor; Marc Lipsitch; William P Hanage
Journal:  Cell       Date:  2021-11-19       Impact factor: 41.582

7.  Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.

Authors:  Jill M Ferdinands; Suchitra Rao; Brian E Dixon; Patrick K Mitchell; Malini B DeSilva; Stephanie A Irving; Ned Lewis; Karthik Natarajan; Edward Stenehjem; Shaun J Grannis; Jungmi Han; Charlene McEvoy; Toan C Ong; Allison L Naleway; Sarah E Reese; Peter J Embi; Kristin Dascomb; Nicola P Klein; Eric P Griggs; Deepika Konatham; Anupam B Kharbanda; Duck-Hye Yang; William F Fadel; Nancy Grisel; Kristin Goddard; Palak Patel; I-Chia Liao; Rebecca Birch; Nimish R Valvi; Sue Reynolds; Julie Arndorfer; Ousseny Zerbo; Monica Dickerson; Kempapura Murthy; Jeremiah Williams; Catherine H Bozio; Lenee Blanton; Jennifer R Verani; Stephanie J Schrag; Alexandra F Dalton; Mehiret H Wondimu; Ruth Link-Gelles; Eduardo Azziz-Baumgartner; Michelle A Barron; Manjusha Gaglani; Mark G Thompson; Bruce Fireman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2022-02-18       Impact factor: 17.586

8.  Has Omicron Changed the Evolution of the Pandemic?

Authors:  Alexander L Lundberg; Ramon Lorenzo-Redondo; Egon A Ozer; Claudia A Hawkins; Judd F Hultquist; Sarah B Welch; P V Vara Prasad; James F Oehmke; Chad J Achenbach; Robert L Murphy; Janine I White; Robert J Havey; Lori Ann Post
Journal:  JMIR Public Health Surveill       Date:  2022-01-31

Review 9.  SARS-CoV-2 Omicron variant: recent progress and future perspectives.

Authors:  Yao Fan; Xiang Li; Lei Zhang; Shu Wan; Long Zhang; Fangfang Zhou
Journal:  Signal Transduct Target Ther       Date:  2022-04-28

10.  New Chimeric Porcine Coronavirus in Swine Feces, Germany, 2012.

Authors:  Valerij Akimkin; Martin Beer; Sandra Blome; Dennis Hanke; Dirk Höper; Maria Jenckel; Anne Pohlmann
Journal:  Emerg Infect Dis       Date:  2016-07-15       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.